Pneumococcal Vaccine in Untreated CLL Patients

Update Il y a 4 ans
Reference: NCT01892618

Woman and Man

  • | Country :
  • Sweden
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of the study is to determine whether patients with chronic lymphocytic leukaemia (CLL) will benefit from vaccination with a 13-valent conjugated pneumococcal vaccine, Prevenar13, compared with a conventional 23-valent capsular polysaccharide vaccine in terms of immune response.


Inclusion criteria

  • Chronic lymphocytic leukemia

Links